Eagle Health Investments’s Centessa Pharmaceuticals CNTA Stock Holding History

Eagle Health Investments’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-214,291	Closed	-$8.51M	–	29
2026 Q1	$8.51M	Buy	214,291 +111,191	+108%	+$2.84M	1.49%	22
2025 Q4	$2.58M	Hold	103,100	–	–	0.57%	24
2025 Q3	$2.5M	Buy	+103,100	New	+$1.83M	0.66%	19

Eagle Health Investments's CNTA Position: Q2 2026 in Review

Eagle Health Investments sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 214,291 shares — an estimated $8.51M sold.

Eagle Health Investments first reported a position in CNTA in Q3 2025 and held it in 3 quarters. The position peaked at $8.51M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Eagle Health Investments reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Eagle Health Investments sold 214,291 Centessa Pharmaceuticals shares in Q2 2026, an estimated $8.51M.
Eagle Health Investments first reported a position in Centessa Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Eagle Health Investments's Centessa Pharmaceuticals position peaked at $8.51M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.